Together let’s provide 100,000 vaccines


Many of us are beginning to get our Covid-19 vaccinations. We’re proud to see our colleagues ‘twinning’ their own vaccinations and fundraising for our #100000vaccines campaign. Schroders is matching any donations made to support UNICEF’s Covid-19 Vaccines Appeal up to our target of 100,000 vaccines. The appeal is supporting with the delivery of 2 billion vaccines, 5.6 million tests and 5.5 million treatments to frontline workers and vulnerable people around the world by the end of 2021.

Twin your vaccine and donate here.

What impact will your donation have?

A £10 (USD $13) donation is £20 to UNICEF and provides 16 doses of Covid-19 vaccines to health workers, teachers or vulnerable people

A £20 (USD $27) donation is £40 to UNICEF and provides 32 doses

A £50 (USD $67) donation is £100 to UNICEF and provides 80 doses

A £100 (USD $138) donation is £200 to UNICEF and provides 160 doses

Or, donate what you can, every donation matters.

Where will the vaccines go and who will benefit?

UNICEF are supporting the delivery of vaccinations in 92 low- to middle-income countries chosen by the World Health Organisation. The initial two billion doses are intended to protect frontline health care and social workers, as well as high risk and vulnerable people.


UNICEF is the only global organisation equipped to deliver an operation of this size. They are the world’s largest vaccine buyer, have more than 70 years’ experience and are on the ground in more than 190 countries. They travel to some of the most remote places on earth to deliver nearly 2 billion doses of life-saving vaccines every year.

Find out more about their campaign.

Important Information: This communication is marketing material. The views and opinions contained herein are those of the author(s) on this page, and may not necessarily represent views expressed or reflected in other Schroders communications, strategies or funds. This material is intended to be for information purposes only and is not intended as promotional material in any respect. The material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. It is not intended to provide and should not be relied on for accounting, legal or tax advice, or investment recommendations. Reliance should not be placed on the views and information in this document when taking individual investment and/or strategic decisions. Past performance is not a reliable indicator of future results. The value of an investment can go down as well as up and is not guaranteed. All investments involve risks including the risk of possible loss of principal. Information herein is believed to be reliable but Schroders does not warrant its completeness or accuracy. Some information quoted was obtained from external sources we consider to be reliable. No responsibility can be accepted for errors of fact obtained from third parties, and this data may change with market conditions. This does not exclude any duty or liability that Schroders has to its customers under any regulatory system. Regions/ sectors shown for illustrative purposes only and should not be viewed as a recommendation to buy/sell. The opinions in this material include some forecasted views. We believe we are basing our expectations and beliefs on reasonable assumptions within the bounds of what we currently know. However, there is no guarantee than any forecasts or opinions will be realised. These views and opinions may change.  To the extent that you are in North America, this content is issued by Schroder Investment Management North America Inc., an indirect wholly owned subsidiary of Schroders plc and SEC registered adviser providing asset management products and services to clients in the US and Canada. For all other users, this content is issued by Schroder Investment Management Limited, 1 London Wall Place, London EC2Y 5AU. Registered No. 1893220 England. Authorised and regulated by the Financial Conduct Authority.